首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

市場調查報告書

商品編碼

1672101

全球生物製程技術市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Bioprocess Technology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 110 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球生物程序技術市場規模預計將從 2024 年的 376.3 億美元成長到 2033 年的 807.8 億美元，在 2026 年至 2033 年的預測期內呈現 8.86% 的強勁年複合成長率(CAGR)。

受生物製藥需求不斷成長和高效生產流程需求的推動，生物製程技術市場正在經歷顯著成長。生物製程技術涵蓋了用於開發和製造生物製品的一系列技術，包括疫苗、單株抗體和重組蛋白。隨著全球生物製藥產業的不斷擴大，對提高生產力和降低成本的先進生物加工解決方案的需求不斷增加。企業正在增加對生物製程技術的投資，以簡化其製造流程並提高產品質量，從而為該市場的強勁擴張做好準備。

此外，生物製程技術的進步正在推動市場創新。連續製造流程、一次性技術和自動化解決方案的發展正在改變生物製藥的生產方式。這些創新不僅提高了效率，還降低了污染風險並提高了可擴展性。隨著生物製程技術市場不斷發展，持續的研究和開發工作將在擴大可用解決方案範圍以滿足生物製藥行業的多樣化需求方面發揮關鍵作用。

此外，對個人化醫療和標靶治療的日益重視正在塑造生物程序技術格局。隨著醫療保健提供者擴大尋求為個別患者量身定做治療方案，對靈活且適應性強的生物加工解決方案的需求可能會增加。這一趨勢在細胞和基因治療領域尤其重要，因為生產客製化的生物製品需要先進的生物加工技術。隨著生物製程技術市場持續成長，技術進步、法規遵循和個人化醫療的推動的整合將在塑造其未來發展軌跡方面發揮關鍵作用，確保生物製藥公司能夠滿足醫療保健領域不斷變化的需求。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：生物製程技術公司的競爭格局

生物製程技術市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Siemens Healthineers

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

Sartorius AG

公司概況
公司收入
產品
最新動態

Becton

公司概況
公司收入
產品
最新動態

Dickinson And Company

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

Eppendorf AG

公司概況
公司收入
產品
最新動態

Lonza

公司概況
公司收入
產品
最新動態

Advanced Instruments

公司概況
公司收入
產品
最新動態

Nova Biomedical

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11213676

Global Bioprocess Technology Market size is anticipated to grow from USD 37.63 Billion in 2024 to USD 80.78 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.86% during the forecast period of 2026 to 2033.

The bioprocess technology market is experiencing significant growth, driven by the increasing demand for biopharmaceuticals and the need for efficient production processes. Bioprocess technology encompasses a range of techniques used to develop and manufacture biological products, including vaccines, monoclonal antibodies, and recombinant proteins. As the global biopharmaceutical industry continues to expand, the demand for advanced bioprocessing solutions that enhance productivity and reduce costs is on the rise. Companies are increasingly investing in bioprocess technology to streamline their manufacturing operations and improve product quality, positioning this market for robust expansion.

Moreover, advancements in bioprocess technology are driving innovation within the market. The development of continuous manufacturing processes, single-use technologies, and automation solutions is transforming the way biopharmaceuticals are produced. These innovations not only enhance efficiency but also reduce the risk of contamination and improve scalability. As the bioprocess technology market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of solutions available to meet the diverse needs of the biopharmaceutical industry.

Additionally, the growing emphasis on personalized medicine and targeted therapies is shaping the bioprocess technology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable bioprocessing solutions is likely to rise. This trend is particularly relevant in the context of cell and gene therapies, where the production of customized biological products requires advanced bioprocessing techniques. As the bioprocess technology market continues to grow, the convergence of technological advancements, regulatory compliance, and the push for personalized medicine will play a pivotal role in shaping its future trajectory, ensuring that biopharmaceutical companies can meet the evolving demands of the healthcare landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

Consumables & Accessories (Culture Media, Reagents, Others)
Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration)

By Application

Primary Surgical
Antibiotics
Recombinant Proteins
Monoclonal Antibodies
Biosimilar

By End-user

Biopharmaceutical Companies
Contract Manufacturing Organization
Contract Research Organization
Food & Feed Industry
Academic Research Organization
COMPANIES PROFILED
Thermo Fisher Scientific Inc.
Siemens Healthineers
GE Healthcare
Sartorius AG
Becton
Dickinson and Company
Danaher Corporation
Eppendorf AG
Lonza
Advanced Instruments
Nova Biomedical
F. Hoffmann-La Roche Ltd.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOPROCESS TECHNOLOGY a€" INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Consumables & Accessories (Culture Media, Reagents, Others) Historic and Forecast Sales By Regions
5.4. Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Historic and Forecast Sales By Regions

6. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Primary Surgical Historic and Forecast Sales By Regions
6.4. Antibiotics Historic and Forecast Sales By Regions
6.5. Recombinant Proteins Historic and Forecast Sales By Regions
6.6. Monoclonal Antibodies Historic and Forecast Sales By Regions
6.7. Biosimilar Historic and Forecast Sales By Regions

7. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Biopharmaceutical Companies Historic and Forecast Sales By Regions
7.4. Contract Manufacturing Organization Historic and Forecast Sales By Regions
7.5. Contract Research Organization Historic and Forecast Sales By Regions
7.6. Food & Feed Industry Historic and Forecast Sales By Regions
7.7. Academic Research Organization Historic and Forecast Sales By Regions

8. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOPROCESS TECHNOLOGY COMPANIES

9.1. Bioprocess Technology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIOPROCESS TECHNOLOGY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Siemens Healthineers
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. GE Healthcare
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Sartorius AG
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Becton
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Dickinson And Company
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Danaher Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Eppendorf AG
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Lonza
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Advanced Instruments
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Nova Biomedical
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. F. Hoffmann-La Roche Ltd
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Consumables & Accessories (Culture Media, Reagents, Others) Market Sales By Geography (USD MN)
Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Primary Surgical Market Sales By Geography (USD MN)
Antibiotics Market Sales By Geography (USD MN)
Recombinant Proteins Market Sales By Geography (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Biosimilar Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
Contract Manufacturing Organization Market Sales By Geography (USD MN)
Contract Research Organization Market Sales By Geography (USD MN)
Food & Feed Industry Market Sales By Geography (USD MN)
Academic Research Organization Market Sales By Geography (USD MN)
Global Bioprocess Technology Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Bioprocess Technology Report
Market Research Process
Market Research Methodology
Global Bioprocess Technology Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-user
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Consumables & Accessories (Culture Media, Reagents, Others) Market Sales By Geography (USD MN)
Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Primary Surgical Market Sales By Geography (USD MN)
Antibiotics Market Sales By Geography (USD MN)
Recombinant Proteins Market Sales By Geography (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Biosimilar Market Sales By Geography (USD MN)
Global Market Analysis By End-user (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
Contract Manufacturing Organization Market Sales By Geography (USD MN)
Contract Research Organization Market Sales By Geography (USD MN)
Food & Feed Industry Market Sales By Geography (USD MN)
Academic Research Organization Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis